Fig. 4From: Decrease in inflammatory biomarker concentration by intervention with selenium and coenzyme Q10: a subanalysis of osteopontin, osteoprotergerin, TNFr1, TNFr2 and TWEAKConcentration of TNFr2 after 6 and 42 months in the placebo and selenium and coenzyme Q10 treatment groups in the total study population. Note: Evaluation performed by use of repeated measures of variance methodology. Note: Current effect: F(1, 215) = 5.6269, p = .01857. Note: Blue curve: Placebo; Red curve: Active treatment group. Values ±95% CI. Vertical bars denote 0.95 confidence intervalsBack to article page